glp-1 cirrhosis Agonists Reduce Risk of in Patients with MASLD -EMJ GI and Hepatology News -

We are moving away from a "one-size-fits-all" and towards personalized lifelong metabolic health management

Following commencement, patients should be monitored for hyperkalaemia (Box 3)

This helps to prevent gastrointestinal side effects like nausea and constipation

Whether you want to lose 100 pounds or 20, or you are stuck at a plateau, or you need help with weight maintenance, our experienced, board-certified clinicians can tailor a GLP-1 program to help you achieve your goals

The real difference often shows up after you start treatmentbecause what happens beyond the prescription is what determines whether results last or fade

Blood sugar rises, and the pancreas releases insulin